Metformin and diabetic kidney disease: a mini-review on recent findings
- PMID: 25793062
- PMCID: PMC4359408
Metformin and diabetic kidney disease: a mini-review on recent findings
Abstract
Metformin, an oral anti-diabetic agent in the biguanide class is a widely prescribed drug to treat high blood glucose in patients with type 2 diabetes mellitus. Metformin has three different roles, including blood glucose regulatory effect, protection of kidney tubular cell by acting as an effective antioxidant and finally ameliorative effect on diabetic kidney disease through saving the podocytes. Therefore, diabetic patients may benefit from all of these three distinct ameliorative effects.
Keywords: Anti-diabetic Agents; Diabetes; Kidney Disease; Metformin.
Similar articles
-
Bright renoprotective properties of metformin: beyond blood glucose regulatory effects.Iran J Kidney Dis. 2013 Nov;7(6):423-8. Iran J Kidney Dis. 2013. PMID: 24241085 Review.
-
Oral antidiabetic agents: current role in type 2 diabetes mellitus.Drugs. 2005;65(3):385-411. doi: 10.2165/00003495-200565030-00005. Drugs. 2005. PMID: 15669880 Review.
-
Metformin reduces TRPC6 expression through AMPK activation and modulates cytoskeleton dynamics in podocytes under diabetic conditions.Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165610. doi: 10.1016/j.bbadis.2019.165610. Epub 2019 Nov 25. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 31778750
-
Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy.Curr Med Chem. 2017;24(31):3397-3412. doi: 10.2174/0929867324666170404143102. Curr Med Chem. 2017. PMID: 28393693 Review.
-
Central anti-diabetic action of biguanide and thizolidinediones in D-glucose fed and streptozotocin-treated mouse models.Neurosci Lett. 2012 Oct 18;528(1):73-7. doi: 10.1016/j.neulet.2012.08.038. Epub 2012 Aug 28. Neurosci Lett. 2012. PMID: 22960361
Cited by
-
AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease.Hum Mol Genet. 2016 Mar 15;25(6):1043-58. doi: 10.1093/hmg/ddv513. Epub 2015 Dec 17. Hum Mol Genet. 2016. PMID: 26681807 Free PMC article.
-
Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy.Molecules. 2019 Aug 6;24(15):2857. doi: 10.3390/molecules24152857. Molecules. 2019. PMID: 31390847 Free PMC article. Review.
-
The effects of ethanol extract of Berberis vulgaris fruit on histopathological changes and biochemical markers of the liver damage in diabetic rats.Iran J Basic Med Sci. 2017 May;20(5):552-556. doi: 10.22038/IJBMS.2017.8681. Iran J Basic Med Sci. 2017. PMID: 28656090 Free PMC article.
-
Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease.Exp Mol Med. 2019 Jun 5;51(6):1-16. doi: 10.1038/s12276-019-0264-9. Exp Mol Med. 2019. PMID: 31165723 Free PMC article.
-
Impact of ATM and SLC22A1 Polymorphisms on Therapeutic Response to Metformin in Iranian Diabetic Patients.Int J Mol Cell Med. 2016 Winter;5(1):1-7. Int J Mol Cell Med. 2016. PMID: 27386433 Free PMC article.
References
-
- Rafieian-Kopaei M. Medicinal plants and the human needs. J HerbMed Plarmacol. 2012;1(1):1–2.
Publication types
LinkOut - more resources
Full Text Sources
Medical